Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

QSAR Studies and Predicted Toxicity of N- Arylhydroxamic Acids (CROSBI ID 642284)

Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | međunarodna recenzija

Jadrijević-Mladar Takač, Milena ; Barbarić, Monika QSAR Studies and Predicted Toxicity of N- Arylhydroxamic Acids // Arhiv za higijenu rada i toksikologiju / Durgo, Ksenija ; Pavlaković, Željana ; Herman, Makso (ur.). 2016. str. 62-62

Podaci o odgovornosti

Jadrijević-Mladar Takač, Milena ; Barbarić, Monika

engleski

QSAR Studies and Predicted Toxicity of N- Arylhydroxamic Acids

The use of biological property predictions has increased in recent years due to improvements in computer technology, the rising costs of drug discovery, and a desire by regulatory agencies to better understand, predict and improve drug safety. Recently, compounds with hydroxamic moiety, i.e., hydroxamic acids (R1CON(OH)R2, R1 = alkyl/aryl and R2 = alkyl/aryl or H) have attracted researchers interest since they show a wide range of biological activities and acceptable toxicities. The aim of this study was to investigate N-arylhydroxamic acids in order to explore their biological activity and potential toxicity in relation to their chemical structures. For this purpose different molecular descriptors including topological indices (MDs, i.e. natoms, Mr, V, MlogP and TIs), drug-likeness (DLs, i.e., GPCR ligand (GPCR l), ion channel modulator (ICM), kinase inhibitor (KI), nuclear receptor ligand (NRL), protease inhibitor (PI) and enzyme inhibitor (EI) and ADMET parameters in comparison with vorinostat* /ADMET Risk (1 – 5.272 ; 3.197*), CYP Risk (0 – 1.055 ; 0.697*), TOX Risk (1 – 2 ; 2*), TOX MUT Risk (1 – 4 ; 2*), TOX hERG Risk (4.541 – 5.579 ; 4.855*)/ have been computed. The relationship between chemical structure either with antitumor activity or predicted toxicity of investigated compounds were analyzed by QSAR methods. Metabolic pathways of N-arylhydroxamic acids with CYP enzymes have been also predicted by ADMET PredictorTM 8.0 (Simulations Plus Inc., USA) and analyzed. Obtained results suggest that some of the investigated N-arylhydroxamic acids are with better toxicological profile comparing to hydroxamic acids registered for clinical use as antitumor agents (e.g., vorinostat and belinostat).

QSAR ; N-arylhydroxamic acids ; molecular descriptors ; drug-likeness ; ADMET properties

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

62-62.

2016.

nije evidentirano

objavljeno

Podaci o matičnoj publikaciji

Arhiv za higijenu rada i toksikologiju

Durgo, Ksenija ; Pavlaković, Željana ; Herman, Makso

Zagreb: Institute for Medical Research and Occupational Health, Zagreb, Hrvatska

0004-1254

1848-6312

Podaci o skupu

5th Croatian Congress of Toxicology with International Participation CROTOX 2016

poster

09.10.2016-12.10.2016

Poreč, Hrvatska

Povezanost rada

Farmacija

Indeksiranost